![Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/18318517-4445-4a35-b4a3-ef837147d7a0/gr1.gif)
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - The Lancet Infectious Diseases
![Diagnosis of ventilator-associated pneumonia: a systematic review of the literature | Critical Care | Full Text Diagnosis of ventilator-associated pneumonia: a systematic review of the literature | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fcc6877/MediaObjects/13054_2008_Article_6310_Fig1_HTML.jpg)
Diagnosis of ventilator-associated pneumonia: a systematic review of the literature | Critical Care | Full Text
![JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm? JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?](https://www.mdpi.com/jcm/jcm-08-01217/article_deploy/html/images/jcm-08-01217-g001.png)
JCM | Free Full-Text | Ventilator-Associated Pneumonia and PaO2/FIO2 Diagnostic Accuracy: Changing the Paradigm?
![JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML](https://www.mdpi.com/jcm/jcm-09-00275/article_deploy/html/images/jcm-09-00275-g001.png)
JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML
![The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care](https://rc.rcjournal.com/content/respcare/60/10/1495/F3.large.jpg)
The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science | Respiratory Care
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment | PLOS ONE
![Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2042474381/2055446457/gr1.jpg)
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection
![Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society](https://openres.ersjournals.com/content/erjor/4/2/00028-2018/F1.large.jpg)
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society
![Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13613-020-00775-4/MediaObjects/13613_2020_775_Fig1_HTML.png)
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study | Annals of Intensive Care | Full Text
![Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f7288031-498e-4705-9bf2-f95eb9659bea/gr1_lrg.gif)
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation - The Lancet Respiratory Medicine
Missouri Society of Health-System Pharmacists - Diagnosis and Treatment of Adults with Community-acquired Pneumonia: 2019 Clinical Practice Guidelines
![Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners](http://bjmp.org/files/2016-9-2/bjmp-2016-9-2-a910a.jpg)
Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | British Journal of Medical Practitioners
![Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-021-03571-z/MediaObjects/13054_2021_3571_Fig1_HTML.png)